Sign inGet started

Posner Christopher

Insider CIK 1748265 · CARA President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CARA Cara Therapeutics, Inc. S Sale2025-02-282025-03-04583$4.75 $2.8K13,109SEC↗
CARA Cara Therapeutics, Inc. S Sale2025-02-042025-02-06372$4.72 $1.8K13,692SEC↗
CARA Cara Therapeutics, Inc. S Sale2024-11-042024-11-063,668$0.29 $1.1K168,768SEC↗
CARA Cara Therapeutics, Inc. S Sale2024-08-012024-08-024,149$0.35 $1.5K172,436SEC↗
CARA Cara Therapeutics, Inc. S Sale2024-05-022024-05-063,936$0.75 $3.0K176,585SEC↗
CARA Cara Therapeutics, Inc. S Sale2024-02-292024-03-045,834$0.89 $5.2K180,521SEC↗
CARA Cara Therapeutics, Inc. S Sale2024-02-082024-02-1235,575$0.53 $18.9K186,355SEC↗
CARA Cara Therapeutics, Inc. S Sale2024-02-012024-02-054,981$0.55 $2.7K221,930SEC↗
CARA Cara Therapeutics, Inc. A Award2024-02-012024-02-0562,500— $0226,911SEC↗
CARA Cara Therapeutics, Inc. S Sale2023-11-022023-11-033,796$1.22 $4.6K164,411SEC↗
CARA Cara Therapeutics, Inc. S Sale2023-08-032023-08-044,307$3.07 $13.2K168,207SEC↗
CARA Cara Therapeutics, Inc. S Sale2023-05-052023-05-093,869$4.40 $17.0K172,514SEC↗
CARA Cara Therapeutics, Inc. S Sale2023-03-032023-03-075,987$9.71 $58.1K176,383SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2023-03-012023-03-03250,000— $0250,000SEC↗
CARA Cara Therapeutics, Inc. S Sale2023-02-022023-02-034,191$11.80 $49.5K182,370SEC↗
CARA Cara Therapeutics, Inc. S Sale2022-11-162022-11-1814,470$11.13 $161.1K186,561SEC↗
CARA Cara Therapeutics, Inc. S Sale2022-04-042022-04-052,006$12.67 $25.4K201,031SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2022-02-252022-03-01121,000— $0121,000SEC↗
CARA Cara Therapeutics, Inc. A Award2022-02-252022-03-0139,000— $0203,037SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2021-10-292021-11-03566,000— $0566,000SEC↗
CARA Cara Therapeutics, Inc. A Award2021-10-292021-11-035,941— $022,037SEC↗
CARA Cara Therapeutics, Inc. A Award2021-10-292021-11-03142,000— $0164,037SEC↗
CARA Cara Therapeutics, Inc. S Sale2021-06-072021-06-072,304$13.04 $30.0K16,096SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2021-06-032021-06-0710,800— $010,800SEC↗
CARA Cara Therapeutics, Inc. A Award2021-06-032021-06-077,200— $018,400SEC↗
CARA Cara Therapeutics, Inc. S Sale2020-11-192020-11-232,000$15.82 $31.6K11,200SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2020-06-042020-06-0810,800— $010,800SEC↗
CARA Cara Therapeutics, Inc. A Award2020-06-042020-06-087,200— $013,200SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2019-06-042019-06-069,000— $09,000SEC↗
CARA Cara Therapeutics, Inc. A Award2019-06-042019-06-066,000— $06,000SEC↗
CARA Cara Therapeutics, Inc. A Award deriv2018-08-022018-08-0635,000— $035,000SEC↗